Anjali Pathak, MD
Psychiatry · Jacksonville, FLNPI 1558448928
Payments from drug & device makers
Across 91 payments — averaging $170.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ironshore Pharmaceuticals Inc.$7K
- Idorsia Pharmaceuticals US Inc$4K
- Tris Pharma Inc$3K
- AbbVie$462
- Otsuka America Pharmaceutical, Inc.$209
- Avanir Pharmaceuticals, Inc.$145
- plus $348 from 10 others
What the payments were for
- Speaking & faculty fees$10,92870%
- Travel & lodging$2,65117%
- Food & beverage$1,95713%
- Gifts$200%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ironshore Pharmaceuticals Inc. | 20 | $6,799 |
| Idorsia Pharmaceuticals US Inc | 4 | $4,200 |
| Tris Pharma Inc | 16 | $3,393 |
| AbbVie(2 entities) | 19 | $462 |
| Otsuka America Pharmaceutical, Inc. | 5 | $209 |
| Avanir Pharmaceuticals, Inc. | 3 | $145 |
| Teva Pharmaceuticals USA, Inc. | 7 | $101 |
| Alkermes, Inc. | 3 | $52 |
| Johnson & Johnson | 3 | $49 |
| Lundbeck LLC | 3 | $43 |
| Neuronetics, Inc. | 3 | $31 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Bausch Health US, LLC | 1 | $16 |
| Neos Therapeutics, LP | 1 | $13 |
| Vertical Pharmaceuticals, LLC | 1 | $12 |
| Arbor Pharmaceuticals, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Jornay PM 20mg capsules (Bottle of 100)$6,322
- QUVIVIQ$4,123
- Dyanavel XR$2,877
- REXULTI$115
- VRAYLAR$110
- NUEDEXTA$108
How this compares
$15,556 in reported general payments places this provider in the 85th percentile of 2,059 psychiatry providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Aripiprazole | 40 | $7,595 |
| PaxilParoxetine Hcl | 17 | $4,782 |
| Bupropion XlBupropion Hcl | 109 | $2,037 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 73 | $1,940 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 55 | $1,704 |
| Lamotrigine | 75 | $1,366 |
| Alprazolam | 246 | $1,355 |
| Duloxetine Hcl | 83 | $1,320 |
| Olanzapine | 28 | $1,018 |
| Clonazepam | 111 | $849 |
| Temazepam | 66 | $826 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 17 | $635 |
| Divalproex Sodium ErDivalproex Sodium | 13 | $617 |
| Quetiapine Fumarate | 32 | $560 |
| Escitalopram Oxalate | 66 | $457 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Jacksonville
- John JoyceJacksonville$13.6M
- Edwin GomezWeston$24.9M
- Rishi KakarTamarac$23.9M
- Peter VentreOakland Park$18.7M
- Jose GamezHialeah$14.8M
- Silvia Silva-DulucMiami$11.7M
- Kelley WilsonTampa$11.1M
- Emilio Mantero-AtienzaMiami Beach$10.9M
- Patricia JunqueraMiami$10.8M
- Olga LapeyraLauderhill$10M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.